Ultragenyx Pharmaceutical
Jung Cho is a highly experienced validation professional with a focus on gene therapy, currently serving as the Director of Validation at Ultragenyx since April 2021, after holding the position of Associate Director. Previous roles include Validation Manager at Mustang Bio, where management of computer system validation and data integrity activities took place, and Senior Validation Engineer at AbbVie, contributing significantly to multiple validation areas including cleaning and temperature mapping. Jung has a robust background in validation across notable companies such as Validation Technologies, Novartis, and Sandoz Pharmaceuticals, with expertise in quality assurance and compliance. Educational accomplishments include a Master’s degree in Operation Regulatory Affairs from Northeastern University, a course in Change Management from Harvard, and a BSc in Chemistry from Université de Montréal, alongside certifications in Six Sigma and leadership training.
This person is not in any teams
This person is not in any offices
Ultragenyx Pharmaceutical
11 followers
Ultragenyx is a biopharmaceutical company focused on the development and commercialization of novel therapies for serious rare and ultra-rare genetic diseases.